Compare Align Technology, Inc. (ALGN) vs PubMatic Inc (PUBM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Align Technology, Inc. vs PubMatic Inc — how do they compare? Align Technology, Inc. trades at $173.38 (market cap $12.29B), while PubMatic Inc trades at $17.52 (market cap $804.41M). The key difference: Align Technology, Inc. is far larger — about 15.3× PubMatic Inc's market cap, and PubMatic Inc is trading nearer its 52-week high, Align Technology, Inc. nearer its low. Which is the better fit depends on your goals.
| ALGN | PUBM | |
|---|---|---|
Market Cap | $12.29B | $804.41M |
Sector | Health | Technology |
52-Week High | $197.51 | $17.78 |
52-Week Low | $124.88 | $6.28 |
Enterprise Value | $11.30B | $707.54M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ALGN trades at $174.63, down 0.8% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported strong Q2 2026 earnings, beating estimates with record revenue and clear aligner volume. Fundamentals show solid profitability with a 68.05% gross margin and 9.99% net income margin, though revenue growth has moderated. Recent news highlights a patent win in China and strategic initiatives following activist investor engagement.
The outlook is mixed: analyst consensus is strongly bullish (73% buy ratings), but technicals and slowing revenue growth pose near-term risks. Investment opportunity lies in international expansion and digital dentistry platform growth, while risks include competitive pressures and execution of new strategic initiatives. The stock's valuation at 30x P/E requires sustained earnings growth to justify.
PUBM trades at $17.18, down 3.27% over 24 hours, with a bullish technical signal from moving averages but bearish oscillators. The company reported a Q2 2026 earnings beat with 11% revenue growth, driven by mobile app and CTV segments, though it remains unprofitable with a negative net income margin. Recent news highlights strategic hires and product launches like AgenticOS to capitalize on AI in advertising.
The outlook is mixed: strong revenue growth and analyst buy ratings support upside to the $20.83 consensus target, but profitability challenges and high valuation ratios pose risks. Investors should weigh the growth potential in high-margin segments against persistent losses and competitive pressures in the ad tech space.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Align Technology, Inc.
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →About PubMatic Inc
PubMatic Inc is engaged in the digital advertising business. The company provides a specialized cloud infrastructure platform that enables real-time programmatic advertising transactions. The platform helps independent app developers and publishers to control and maximize their digital advertising businesses.
Read more on PUBM →
